Major histocompatibility complex class I molecules with super-enhanced CD8 binding properties bypass the requirement for cognate TCR recognition and non-specifically activate cytotoxic T lymphocytes1

Ítems similars

• Modification of MHC anchor residues generates heteroclitic peptides that alter TCR binding and T-cell recognition
  per: Cole, David K, et al.
  Publicat: (2010)
• Magnetic-Activated Cell Sorting of TCR-Engineered T Cells, Using tCD34 as a Gene Marker, but Not Peptide–MHC Multimers, Results in Significant Numbers of Functional CD4(+) and CD8(+) T Cells
  per: Govers, Coen, et al.
  Publicat: (2012)
• T Cells Expressing a TCR-Like Antibody Selected Against the Heteroclitic Variant of a Shared MAGE-A Epitope Do Not Recognise the Cognate Epitope
  per: Saeed, Mesha, et al.
  Publicat: (2020)
• Anti-CD8 antibodies can trigger CD8(+) T-cell effector function in the absence of TCR engagement and improve pMHCI tetramer staining
  per: Clement, Mathew, et al.
  Publicat: (2011)
• T-cell Receptor (TCR)-Peptide Specificity Overrides Affinity-enhancing TCR-Major Histocompatibility Complex Interactions
  per: Cole, David K., et al.
  Publicat: (2014)